Table 3 Univariate analysis for overall survival in lung cancer patients with malignant pleural effusion a
From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients
Parameters | Patients ( n) | OS (months) | P-value |
|---|---|---|---|
Age (years) | 0.038* | ||
≥60 | 38 | 5.1 | |
<60 | 40 | 9.4 | |
Gender | 0.538 | ||
Male | 36 | 8.7 | |
Female | 42 | 6.2 | |
IL-17 (pg/ml) | 0.023* | ||
≥15 | 26 | 4.7 | |
<15 | 52 | 10.8 | |
ECOG PS | 0.011* | ||
0 or 1 | 50 | 9.4 | |
2 to 4 | 28 | 3.1 | |
Histologic type | 0.617 | ||
Adenocarcinoma | 67 | 7.5 | |
Nonadenocarcinoma | 11 | 5.3 | |
Stage | 0.047* | ||
M1a | 54 | 8.6 | |
M1b | 24 | 4.2 | |
Location | 0.636 | ||
Right | 50 | 7.3 | |
Left | 28 | 6.9 |